Philippe Crine

USPTO Granted Patents = 11 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 259(Granted Patents)

Company Filing History:

4 out of 196

Alexion Pharmaceuticals, Inc.

Universitéde Montreal

patents

4. 1 out of 1

Alexion Pharmaceuticsl, Inc.

patent

5. 1 out of 1,155

Vanderbilt University

patents

where one patent can have more than one assignee

Years Active: 2004-2022

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11248021 - Bone delivery conjugates and method of using same to target proteins to bone (2022-02-15),

2. 10052366 - Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof (2018-08-21),

3. 10000532 - Bone delivery conjugates and method of using same to target proteins to bone (2018-06-19),

4. 9988620 - Methods, compositions, and kits for the treatment of matrix mineralization disorders (2018-06-05),

5. 9266939 - Compositions comprising natriuretic peptides and methods of use thereof (2016-02-23),

6. 7960529 - Bone delivery conjugates and method of using same to target proteins to bone (2011-06-14),

7. 7763712 - Bone delivery conjugates and method of using same to target proteins to bone (2010-07-27),

8. 7427498 - Composition, methods and reagents for the synthesis of a soluble form of human PHEX (2008-09-23),

9. 7365091 - Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX (2008-04-29),

10. 7105539 - Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex (2006-09-12),

11. 6790649 - Composition, methods and reagents for the synthesis of a soluble form of human PHEX (2004-09-14),

Title: The Innovative Contributions of Philippe Crine

Introduction

Philippe Crine is a notable inventor based in Outremont, Canada. He has made significant contributions to the field of biomedical engineering, particularly in the development of novel therapeutic methods and compositions. With a total of 11 patents to his name, Crine's work has the potential to impact various medical conditions.

Latest Patents

Crine's latest patents include groundbreaking inventions such as bone delivery conjugates and methods for targeting proteins to bone. These conjugates are designed with specific structures that enhance their effectiveness in delivering therapeutic agents. Additionally, he has developed compositions that comprise alkaline phosphatase and/or natriuretic peptide, which are aimed at treating neurocutaneous syndromes and other disorders. His innovative approaches also involve polypeptides that can be administered subcutaneously to address various medical conditions, including bone elongation.

Career Highlights

Throughout his career, Philippe Crine has worked with prominent companies in the pharmaceutical industry, including Alexion Pharmaceuticals, Inc. and Enobia Pharma Inc. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in medical treatments.

Collaborations

Crine has collaborated with esteemed colleagues such as Guy Boileau and Isabelle Lemire. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Philippe Crine's contributions to the field of biomedical engineering are noteworthy and demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a leading inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.